logo

For the Inventor, By the Inventor

Toronto, Canada

Interface Biologics, Inc.


USPTO Granted Patents = 21

% Expired Patents = 28.6



Trademarks = 3

Forward Citations = 204

Loading Chart...
Loading Chart...

26 inventors (with patents filed for the assignee):

goldMedal Paul Joseph Santerre (12 out of 38 patents)

silverMedal Roseita Esfand (10 out of 12 patents)

bronzeMedal Sanjoy Mullick (8 out of 15 patents)

4.  Weilun Chang (7 out of 11 patents)

5.  Hanje Chen (5 out of 6 patents)

6.  Jeannette Ho (4 out of 13 patents)

7.  Mark A Steedman (4 out of 5 patents)

8.  Richard Witmeyer (4 out of 5 patents)

9.  Raymond Lareau (3 out of 35 patents)

10.  Benjamin Bell (3 out of 18 patents)

11.  Bernadette Ilagan (3 out of 3 patents)

12.  Meilin Yang (3 out of 3 patents)

13.  Alexandra Piotrowicz (3 out of 4 patents)

14.  Frank Laronde (3 out of 3 patents)

15.  Sylvia Tjahyadi (2 out of 2 patents)


21 patents:

1. 11766511 - Antithrombogenic hollow fiber membranes and filters (2023-09-26),
2. 11318232 - Compositions and methods for delivering drugs to a vessel wall (2022-05-03),
3. 10195311 - Local delivery of drugs from self assembled coatings (2019-02-05),
4. 10039864 - Oligofluorinated cross-linked polymers and uses thereof (2018-08-07),
5. 9884146 - Antithrombogenic hollow fiber membranes and filters (2018-02-06),
6. 9764884 - Packaging materials including a barrier film (2017-09-19),
7. 9744269 - Thermoplastic polyurethane admixtures (2017-08-29),
8. 9206283 - Thermoplastic polyurethane admixtures (2015-12-08),
9. 8962697 - Bioreponsive polymers (2015-02-24),
10. 8900603 - Local delivery of drugs from self assembled coatings (2014-12-02),
11. 8877062 - Antithrombogenic hollow fiber membranes and filters (2014-11-04),
12. 8784402 - Catheters with fluoropolymer additives (2014-07-22),
13. 8574604 - Methods and compositions for the delivery of biologically active agents (2013-11-05),
14. 8445016 - Grafted polymers and uses thereof (2013-05-21),
15. 8440176 - Covalently grafted pharmaceutically active polymers (2013-05-14),
Company Overview
Interface Biologics, Inc. is a Toronto-based company specializing in advanced biomaterials and drug delivery systems. The organization focuses on developing innovative solutions for medical devices, particularly in the areas of cardiovascular and orthopedic applications. By leveraging its expertise in surface modification and biocompatibility, Interface Biologics aims to enhance patient outcomes and reduce complications associated with implanted devices. The company's research is pivotal in bridging the gap between material science and clinical applications.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

21 Patents

#82 in Toronto

#685 in Canada

#29,928 in the World

Toronto, CA
Toronto, Canada

Interface Biologics, Inc.

Forward Citations = 204

26 inventors:

goldMedal Paul Joseph Santerre (12 out of 38 patents)

silverMedal Roseita Esfand (10 out of 12 patents)

bronzeMedal Sanjoy Mullick (8 out of 15 patents)

4.  Weilun Chang (7 out of 11 patents)

5.  Hanje Chen (5 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Interface Biologics, Inc.. Retrieved from https://idiyas.com/company/interface-biologics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…